Christiaan De Wilde
From Wikipedia, the free encyclopedia
Christiaan De Wilde is a Belgian businessman, and he is at present the Chief Executive Officer of the Belgian biotech company Innogenetics.
[edit] Education
Christiaan De Wilde graduated in Accountancy at the Hogeschool Gent (BME) (Ghent) and obtained a degree in Taxation and a Masters degree in Industrial Entrepreneurship, both at EHSAL (Brussels).
[edit] Career
In October 1988, he started his career at Johnson & Johnson, where he would stay for 17 years. From June 2000 until May 2005, he was Finance & Logistics Director for the Benelux and a member of the Board of Johnson & Johnson Medical BV (Netherlands). Until August 2006, he was Finance & Logistics Director and a member of the Board of Janssen-Cilag Belgium NV.
On 1 September 2006, he was appointed Chief Financial and Administration Officer of Innogenetics and on 15 October 2007, he became Executive Officer and a member of the Board.
[edit] Source
- Christiaan De Wilde
- Innogenetics appoints Christiaan De Wilde as Chief Financial Officer
- Innogenetics names Christiaan De Wilde as CFO from Sept 1
This Belgian biographical article is a stub. You can help Wikipedia by expanding it.
